CTT Pharmaceutical CEO acquires 78 worth of company stock By Investing.com - Investing.com

CTTH Stock  USD 0.08  0.01  9.37%   
Under 61% of CTT Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading CTT Pharmaceutical Holdings pink sheet suggests that many investors are alarmed at this time. CTT Pharmaceutical's investing sentiment shows overall attitude of investors towards CTT Pharmaceutical Holdings.
  
CTT Pharmaceutical CEO acquires 78 worth of company stock By Investing.com Investing.com

Read at news.google.com
Google News at Macroaxis
  

CTT Pharmaceutical Fundamental Analysis

We analyze CTT Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CTT Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CTT Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

CTT Pharmaceutical is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Peers

Trending Equities

C  3.06   
0%
100.0%
AAL  1.46   
0%
47.0%
WFC  1.43   
0%
46.0%
T  0.94   
0%
30.0%
IBM  0.81   
0%
26.0%
CVX  0.76   
0%
24.0%
UPS  0.50   
0%
16.0%
BBY  0.00   
0%
0%
AAPL  0.00   
0%
0%
AA  0.38   
12.0%
0%
TGT  0.54   
17.0%
0%
S  0.68   
22.0%
0%
HD  0.71   
23.0%
0%
MET  0.78   
25.0%
0%
CVS  0.81   
26.0%
0%
INTC  2.20   
71.0%
0%

Complementary Tools for CTT Pink Sheet analysis

When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.